LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer—Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 17 (2) , e217-e228
Abstract
No abstract availableKeywords
Funding Information
- Fondazione del Monte di Bologna e Ravenna
- Associazione Italiana per la Ricerca sul Cancro (IG14281)
This publication has 29 references indexed in Scilit:
- The Complete Exosome Workflow Solution: From Isolation to Characterization of RNA CargoBioMed Research International, 2013
- Tetraspanin CO-029 Inhibits Colorectal Cancer Cell Movement by Deregulating Cell-Matrix and Cell-Cell AdhesionsPLOS ONE, 2012
- Intratumor Heterogeneity and Branched EvolutionNew England Journal of Medicine, 2012
- Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysisExperimental and Therapeutic Medicine, 2011
- TRAM (Transcriptome Mapper): database-driven creation and analysis of transcriptome maps from multiple sourcesBMC Genomics, 2011
- E-Cadherin/p120-Catenin and Tetraspanin Co-029 Cooperate for Cell Motility Control in Human Colon CarcinomaCancer Research, 2010
- Cell Surface Tetraspanin Tspan8 Contributes to Molecular Pathways of Exosome-Induced Endothelial Cell ActivationCancer Research, 2010
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Galectin-4 Binds to Sulfated Glycosphingolipids and Carcinoembryonic Antigen in Patches on the Cell Surface of Human Colon Adenocarcinoma CellsJournal of Biological Chemistry, 2005
- Carcinoembryonic Antigen Family Members CEACAM6 and CEACAM7 Are Differentially Expressed in Normal Tissues and Oppositely Deregulated in Hyperplastic Colorectal Polyps and Early AdenomasThe American Journal of Pathology, 2000